Lixte Biotechnology Holdings, Inc. logo

Lixte Biotechnology Holdings, Inc. Employee Directory

Biotechnology ResearchNew York, United States2-10 Employees

Lixte Biotechnology Holdings, Inc. is a small, publicly traded biotechnology company based in East Setauket, New York, focused on developing therapies for cancer. Its portfolio centers on inhibitors of protein phosphatases that regulate cell division and DNA damage repair, as well as inhibitors of protein deacetylases that influence gene expression and protein degradation. The lead compound LB-100 is in a Phase I trial and is described as potentially first-in-class. 

The company aims to augment existing cancer treatments, with phosphatase inhibitors expected to enhance the effectiveness of standard chemotherapy and radiation, and to be used in combination with other targeted therapies. Deacetylase inhibitors show anti-cancer activity in models and have potential applications beyond cancer, including certain inherited metabolic diseases and neurodegenerative conditions. In April 2026, Lixte announced preliminary results from a clinical trial combining LB-100 with Dostarlimab at the Society of Gynecologic Oncology conference in San Juan, Puerto Rico.

Find Lixte Biotechnology Holdings, Inc. employees' phone numbers or email addresses

Lixte Biotechnology Holdings, Inc. Global Highlights

Location
Employees

North America
10

Minus sign iconPlus sign icon
  • United States Of America
    10

Europe
2

Minus sign iconPlus sign icon
  • Netherlands
    2

Lixte Biotechnology Holdings, Inc.'s Leadership

  • Cmo at Lixte Biotechnology Holdings, Inc.
    J. M.
    Cmo
  • Chief Technology Officer at Lixte Biotechnology Holdings, Inc.
    B. B. V. D. B.
    Chief Technology Officer

Lixte Biotechnology Holdings, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Entrepreneurship
  • Other

Contact profiles from Lixte Biotechnology Holdings, Inc.

Name
Title
Contact
Location
Last Update
  • Chief Technology Officer at Lixte Biotechnology Holdings, Inc.
    B. B. V. D. B.
    Chief Technology Officer
    Netherlands, North Holland
    Aug 26, 2026
  • Cmo at Lixte Biotechnology Holdings, Inc.
    J. M.
    Cmo
    Oct 21, 2024

Frequently Asked Questions

What is Lixte Biotechnology Holdings, Inc. known for?

Minus sign iconPlus sign icon
Lixte Biotechnology Holdings, Inc. was founded in 2006 and operates in the Biotechnology Research industry. You can contact Lixte Biotechnology Holdings, Inc.'s main corporate office by phone at . Explore Lixte Biotechnology Holdings, Inc.'s company overview page for more information.

What is Lixte Biotechnology Holdings, Inc.'s most common email format?

Minus sign iconPlus sign icon
Lixte Biotechnology Holdings, Inc. employees' email format typically follows the pattern of FLast@lixte.com. Trying to find reliable and up-to-date employee contact data? Find more Lixte Biotechnology Holdings, Inc. email formats with LeadIQ.

How many employees does Lixte Biotechnology Holdings, Inc. have currently?

Minus sign iconPlus sign icon
Lixte Biotechnology Holdings, Inc. has approximately 4 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Lixte Biotechnology Holdings, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Lixte Biotechnology Holdings, Inc.'s key employees include:

  • Cmo: J. M.
  • Chief Technology Officer: B. B. V. D. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.